can contribute to potent efficacy, a longer period in plasma or the target tissues might lead to powerful efficacy. As talked over from the Xenon/Genentech group,one hundred and one compounds with sharp PK profiles (significant blood stage peaks) would lead to in vivo coupled with their construct